Semble is a burgeoning player in the Health Care industry, offering a comprehensive EHR and practice management system designed for the private healthcare sector. Founded in 2016 and headquartered in the United Kingdom, Semble serves a wide clientele across the UK and France, catering to over 1,500 companies including individual consultants, GPs, and large corporate healthcare providers.
The platform simplifies healthcare management by streamlining daily operations such as scheduling, billing, and reporting, while providing clinicians with a unified interface for recording, treating, and prescribing medications.
Semble has proven its growth potential by securing a substantial £11.60M Series B investment on 23 October 2024. This funding round was led by reputable investors like Octopus Ventures, Smedvig Capital, Triple Point Ventures, and Mercia Asset Management. Such backing underscores confidence in Semble's ability to scale and innovate within a competitive market.